Indeed, all CoSCLCs showed simultaneous alteration of TP53 and RB1, while CoADCs showed frequent alterations of KRAS, KEAP1 and STK11 or the presence of ALK-EML4 fusion gene in line with the genomic profile of histologically pure SCLC and ADC, respectively. This evidence concerns the gene ALK and small cell lung carcinoma.